Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |